SARS-CoV-2 virus B.1. 1.529 mutant strain DNA vaccine and application
The invention relates to the technical field of biology, and particularly provides an SARS-CoV-2 virus B.1. 1.529 mutant strain DNA (Deoxyribose Nucleic Acid) vaccine and application thereof. The SEQ ID NO: 1 sequence provided by the invention can be efficiently transcribed and expressed in a eukary...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to the technical field of biology, and particularly provides an SARS-CoV-2 virus B.1. 1.529 mutant strain DNA (Deoxyribose Nucleic Acid) vaccine and application thereof. The SEQ ID NO: 1 sequence provided by the invention can be efficiently transcribed and expressed in a eukaryotic expression system, has immunogenicity, and is expressed in humoral immune and cellular immune response, and the nucleic acid vaccine taking the SEQ ID NO: 1 sequence as an active component also has good immunogenicity.
本发明涉及生物技术领域,具体而言,提供了一种SARS-CoV-2病毒B.1.1.529突变株DNA疫苗及应用。本发明提供的SEQ ID NO:1序列在真核表达系统中能够高效转录和表达,而且具有免疫原性,表现在体液免疫和细胞免疫应答,以此作为活性成分的核酸疫苗同样具有良好的免疫原性。 |
---|